147 lines
44 KiB
Text
147 lines
44 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK98128">
|
|
<meta name="ncbi_domain" content="micad">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK98128/?report=reader">
|
|
<meta name="ncbi_pagename" content="5-(2-[18F]Fluoroethoxy)-L-tryphan - Molecular Imaging and Contrast Agent Database (MICAD) - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>5-(2-[18F]Fluoroethoxy)-L-tryphan - Molecular Imaging and Contrast Agent Database (MICAD) - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/micad/BrFPN/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/micad/FPHBF-2-18F/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/micad/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="Molecular Imaging and Contrast Agent Database (MICAD) [Internet]">
|
|
<meta name="citation_title" content="5-(2-[18F]Fluoroethoxy)-L-tryphan">
|
|
<meta name="citation_publisher" content="National Center for Biotechnology Information (US)">
|
|
<meta name="citation_date" content="2012/06/28">
|
|
<meta name="citation_author" content="Kam Leung">
|
|
<meta name="citation_pmid" content="22764388">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK98128/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="5-(2-[18F]Fluoroethoxy)-L-tryphan">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Center for Biotechnology Information (US)">
|
|
<meta name="DC.Contributor" content="Kam Leung">
|
|
<meta name="DC.Date" content="2012/06/28">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK98128/">
|
|
<meta name="description" content="A variety of 11C- and 18F-labeled amino acids have been studied for potential use in positron emission tomography (PET) oncology (1, 2). Most brain tumors show an increased uptake of amino acids as compared with normal brain tissues (3). These amino acids are composed of naturally occurring amino acids, such as L-[11C]leucine, S-[11C]methyl-L-methionine ([11C]MET), and L-[11C]tyrosine, and non-natural amino acids, such as [11C]aminoisobutyric acid, [11C]1-aminocyclopentane-1-carboxylic acid, and [11C]1-aminocyclobutane-1-carboxylic acid. 123I-Labeled amino acids are also used in oncological imaging (1, 4, 5).">
|
|
<meta name="og:title" content="5-(2-[18F]Fluoroethoxy)-L-tryphan">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="A variety of 11C- and 18F-labeled amino acids have been studied for potential use in positron emission tomography (PET) oncology (1, 2). Most brain tumors show an increased uptake of amino acids as compared with normal brain tissues (3). These amino acids are composed of naturally occurring amino acids, such as L-[11C]leucine, S-[11C]methyl-L-methionine ([11C]MET), and L-[11C]tyrosine, and non-natural amino acids, such as [11C]aminoisobutyric acid, [11C]1-aminocyclopentane-1-carboxylic acid, and [11C]1-aminocyclobutane-1-carboxylic acid. 123I-Labeled amino acids are also used in oncological imaging (1, 4, 5).">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK98128/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-micad-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/micad/FEHTP18F/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK98128/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8CAE417D63E1D10000000000C700AD.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK98128/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/micad/BrFPN/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">5-(2-[18F]Fluoroethoxy)-L-tryphan</div><div class="j">Molecular Imaging and Contrast Agent Database (MICAD) [Internet]</div></div><div class="tail"><a href="/books/n/micad/FPHBF-2-18F/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK98128/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK98128/&text=5-(2-%5B18F%5DFluoroethoxy)-L-tryphan"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/micad/?report=reader">Title Information</a><a href="/books/n/micad/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK98128/?report=classic">Switch to classic view</a><a href="/books/NBK98128/pdf/Bookshelf_NBK98128.pdf">PDF (144K)</a><a href="/books/NBK98128/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK98128%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8CAE417D63E1D10000000000C700AD.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK98128_"><span class="title" itemprop="name"><span class="small-caps">5-(2-</span>[<sup>18</sup>F]Fluoroethoxy)-<span class="small-caps">L</span>-tryphan</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">[<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP</div><p class="contribs">Leung K.</p><p class="fm-aai"><a href="#_NBK98128_pubdet_">Publication Details</a></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figFEHTP18FTncchemicalname5218ffluoroet"><a href="/books/NBK98128/table/FEHTP18F.T.nc_chemical_name5218ffluoroet/?report=objectonly" target="object" title="Table" class="img_link icnblk_img" rid-ob="figobFEHTP18FTncchemicalname5218ffluoroet"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="FEHTP18F.T.nc_chemical_name5218ffluoroet"><a href="/books/NBK98128/table/FEHTP18F.T.nc_chemical_name5218ffluoroet/?report=objectonly" target="object" rid-ob="figobFEHTP18FTncchemicalname5218ffluoroet">Table</a></h4><p class="float-caption no_bottom_margin">
|
|
|
|
<i>In vitro</i>
|
|
|
|
|
|
Rodents
|
|
</p></div></div><div id="FEHTP18F.Background"><h2 id="_FEHTP18F_Background_">Background</h2><p>[<a href="/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=FEHTP" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed</a>]</p><p>A variety of <sup>11</sup>C- and <sup>18</sup>F-labeled amino acids have been studied for potential use in positron emission tomography (PET) oncology (<a class="bibr" href="#FEHTP18F.REF.1" rid="FEHTP18F.REF.1 FEHTP18F.REF.2">1, 2</a>). Most brain tumors show an increased uptake of amino acids as compared with normal brain tissues (<a class="bibr" href="#FEHTP18F.REF.3" rid="FEHTP18F.REF.3">3</a>). These amino acids are composed of naturally occurring amino acids, such as L-[<sup>11</sup>C]leucine, <i>S</i>-[<sup>11</sup>C]methyl-L-methionine ([<sup>11</sup>C]MET), and L-[<sup>11</sup>C]tyrosine, and non-natural amino acids, such as [<sup>11</sup>C]aminoisobutyric acid, [<sup>11</sup>C]1-aminocyclopentane-1-carboxylic acid, and [<sup>11</sup>C]1-aminocyclobutane-1-carboxylic acid. <sup>123</sup>I-Labeled amino acids are also used in oncological imaging (<a class="bibr" href="#FEHTP18F.REF.1" rid="FEHTP18F.REF.1 FEHTP18F.REF.4 FEHTP18F.REF.5">1, 4, 5</a>).</p><p>Some 20 amino acid transporter systems have been identified (<a class="bibr" href="#FEHTP18F.REF.1" rid="FEHTP18F.REF.1">1</a>). Most amino acids are taken up by tumor cells through an energy-independent L-type amino acid transporter (LAT) system, a Na-dependent transporter system A, or a Na<sup>+</sup>-dependent system B<sup>0</sup> (<a class="bibr" href="#FEHTP18F.REF.6" rid="FEHTP18F.REF.6">6</a>). They are retained in tumor cells due to their metabolic activities, including incorporation into proteins, which are higher than most normal cells (<a class="bibr" href="#FEHTP18F.REF.1" rid="FEHTP18F.REF.1">1</a>). Malignant transformation increases the use of amino acids for energy, protein synthesis, and cell division. Tumor cells have been found to have overexpressed transporter systems (<a class="bibr" href="#FEHTP18F.REF.7" rid="FEHTP18F.REF.7">7</a>). L-[<sup>11</sup>C]MET, [<sup>18</sup>F]fluorotyrosine, L-[<sup>11</sup>C]leucine, and [<sup>18</sup>F]fluoro-α-methyl tyrosine have been widely used in the detection of tumors (<a class="bibr" href="#FEHTP18F.REF.2" rid="FEHTP18F.REF.2 FEHTP18F.REF.6">2, 6</a>) but are not approved by the United States Food and Drug Administration. These agents are moved into cells by various amino acid transporters and are incorporated into proteins. The fraction of radiolabeled amino acid that is incorporated into protein is usually small compared to the total amount taken up into the cell, except for leucine which is incorporated into proteins, quantitatively. These natural amino acid images are based on amino acid transport and protein incorporation.</p><p>5-(2-[<sup>18</sup>F]Fluoroethoxy)-L-tryphan ([<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP), unlike L-3,4-dihydroxy-6-[<sup>18</sup>F]fluorophenylalanine (<a href="/books/NBK23043/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">[<sup>18</sup>F]FDOPA</a>), is only a substrate of LAT1 and is not a substrate of aromatic <span class="small-caps">L</span>-amino acid decarboxylase (AADC). [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP was evaluated as a PET tumor imaging agent in mice with comparison to [<sup>18</sup>F]fluoro-2-deoxy-2-<span class="small-caps">d</span>-glucose (<a href="/books/NBK23335/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">[18F]FDG</a>) and [<sup>18</sup>F]FDOPA (<a class="bibr" href="#FEHTP18F.REF.8" rid="FEHTP18F.REF.8 FEHTP18F.REF.9">8, 9</a>).</p><div id="FEHTP18F.Related_Resource_Links"><h3>Related Resource Links:</h3><ul><li class="half_rhythm"><div>Chapters in MICAD (<a href="/sites/entrez?Db=books&Cmd=DetailsSearch&Term=amino%20acid%20(transporter%20OR%20transporters)+AND+micad%5Bbook%5D" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Amino acid transporters</a>)</div></li><li class="half_rhythm"><div>Gene information in NCBI (<a href="/gene/8140" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">L-type amino acid transporter 1</a>, <a href="/gene/23428" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">L-type amino acid transporter 2</a>, <a href="/gene/54407" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">A-type amino acid transporter</a>)</div></li><li class="half_rhythm"><div>Articles in Online Mendelian Inheritance in Man (OMIM) (<a href="/omim?Db=omim&Cmd=DetailsSearch&Term=amino%5BAll+Fields%5D+AND+acid%5BAll+Fields%5D+AND+transporter%5BAll+Fields%5D" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Amino acid transporters</a>)</div></li><li class="half_rhythm"><div>Clinical trials (<a href="http://www.clinicaltrials.gov/ct2/results?term=amino+acid+transporters" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Amino acid transporters</a>, <a href="http://www.clinicaltrials.gov/ct2/results?term=11C+MET" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">L-[<sup>11</sup>C]methionine</a>)</div></li><li class="half_rhythm"><div>Drug information in FDA (<a href="http://google2.fda.gov/search?q=amino+acid+transporters&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&getfields=*&x=13&y=15" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Amino acid transporters</a>, <a href="http://google2.fda.gov/search?q=11C-methionine+&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&getfields=*&x=8&y=8" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">L-[<sup>11</sup>C]methionine</a>)</div></li></ul></div></div><div id="FEHTP18F.Synthesis"><h2 id="_FEHTP18F_Synthesis_">Synthesis</h2><p>[<a href="/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=FEHTP%20and%20synthesis" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed</a>]</p><p> [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP was synthesized by direct alkylation of 5-hydroxy-<span class="small-caps">L</span>-tryptophan with [<sup>18</sup>F]fluoroethyltosylate for 10 min at 90°C (<a class="bibr" href="#FEHTP18F.REF.9" rid="FEHTP18F.REF.9">9</a>). [<sup>18</sup>F]Fluoroethyltosylate was prepared by [<sup>18</sup>F]-fluorination of ethylene glycol-1,2-ditosylate with [<sup>18</sup>F]-potassium Kryptofix complex for 15 min at 100°C. This two-step automated synthesis provided [<sup>18</sup>F]-L-FEHTP with 12%–16% overall yield and a radiochemical purity >98% with a total synthesis time of ~40 min. The specific activities of [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP was 50–150 GBq/μmol (1.35–4.05 Ci/μmol).</p></div><div id="FEHTP18F.In_Vitro_Studies_Testing_in_Cel"><h2 id="_FEHTP18F_In_Vitro_Studies_Testing_in_Cel_"><i>In Vitro</i> Studies: Testing in Cells and Tissues</h2><p>[<a href="/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=FEHTP%20and%20in%20vitro" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed</a>]</p><p>Kramer et al. (<a class="bibr" href="#FEHTP18F.REF.8" rid="FEHTP18F.REF.8">8</a>) showed that [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP accumulation in NCI-H69 endocrine small cell lung cancer cells, PC-3 prostate cancer cells, and MDA-MB-231 breast cancer cells was reduced by >95% in the presence of 10 mM 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH, an L-type transporter inhibitor). The radioactivity accumulation of [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP was 48%–113% incubation dose (ID)/mg protein in the absence of BCH. The ADCC inhibitor <i>S</i>-carbidopa had little effect on the [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP accumulation in these cells, suggesting that decarboxylation was not involved in the accumulation. On the other hand, <i>S</i>-carbidopa almost completely abolished the accumulation of [<sup>18</sup>F]FDOPA (26%–53% ID/mg protein).</p></div><div id="FEHTP18F.Animal_Studies"><h2 id="_FEHTP18F_Animal_Studies_">Animal Studies</h2><div id="FEHTP18F.Rodents"><h3>Rodents</h3><p>[<a href="/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=FEHTP%20and%20rodentia" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed</a>]</p><p><i>Ex vivo</i> tissue accumulation of [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP was studied in mice (<i>n</i> = 6/group) bearing S180 fibrosarcoma at 15, 30, 60, and 120 min after injection of 0.74 MBq (0.02 mCi) of the tracer as reported by Li et al. (<a class="bibr" href="#FEHTP18F.REF.9" rid="FEHTP18F.REF.9">9</a>). The tumor accumulation of radioactivity was 3.07 ± 1.04% injected dose (ID)/g, 4.61 ± 1.18% ID/g, 5.19 ± 0.79% ID/g, and 2.37 ± 0.23% ID/g at 15, 30, 60, and 120 min, respectively. The tissue with the highest uptake was the liver (4.59%), followed by the kidney (4.05% ID/g), lung (3.86% ID/g), small intestine (3.65% ID/g), brain (3.18% ID/g), spleen (3.15% ID/g), heart (2.41% ID/g), muscle (2.04% ID/g), bone (1.94% ID/g), and blood (1.91% ID/g) at 30 min. All tissues showed moderate washout. The maximal tumor/blood and tumor/muscle ratios at 60 min were 2.87 and 2.79, respectively. [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP remained >95% intact and no other radioactive metabolites were detected in the blood, brain, and tumors at 15 and 60 min after injection. No blocking studies were performed.</p><p>In a separate study, accumulation of [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP (<i>n</i> = 4) and [<sup>18</sup>F]FDG (<i>n</i> = 4) was compared in mice with tumors and <i>Staphylococcus aureus</i>-induced inflammation in thigh muscle. [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP exhibited tumor/muscle and inflammation/muscle ratios of 2.79 and 0.94, respectively, at 60 min after injection. On the other hand, [<sup>18</sup>F]FDG exhibited tumor/muscle and inflammation/muscle ratios of 2.91 and 3.17, respectively, at 60 min after injection. Whole-body PET imaging at 60 min after injection showed high [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP and [<sup>18</sup>F]FDG accumulation in the tumors, whereas low [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP and high [<sup>18</sup>F]FDG accumulation were observed in the inflammation.</p><p>Kramer et al. (<a class="bibr" href="#FEHTP18F.REF.8" rid="FEHTP18F.REF.8">8</a>) performed <i>ex vivo</i> biodistribution studies in nude mice bearing NCI-H69 (<i>n</i> = 3) or PC-3 xenografts (<i>n</i> = 4) at 70 min after injection of [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP. The tumor accumulation of radioactivity (standard uptake value (SUV)) was 1.58 ± 0.48 and 1.40 ± 0.35 in the NCI-H69 and PC-3 tumors, respectively. The tissue with the highest SUV was the pancreas (8.50), followed by the kidney (2.05), spleen (0.88), brain (0.84), liver (0.81), heart (0.78), and blood (0.75). Pretreatment with tryptophan (25 mg/kg, 10 min) resulted in a slight decrease (not significant) of tissue accumulation in the NCI-H69 tumors, brain, and kidneys but had little effect on the other tissues.</p><p>Kramer et al. (<a class="bibr" href="#FEHTP18F.REF.8" rid="FEHTP18F.REF.8">8</a>) performed PET imaging studies in mice (<i>n</i> = 3–7/group) bearing NCI-H69 or PC-3 tumors after injection of [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP or [<sup>18</sup>F]FDOPA. Dynamic and static PET scans showed the accumulation of both tracers in the two tumors with SUV of ~1.5. Pretreatment with <i>S</i>-carbidopa 60 min before [<sup>18</sup>F]FDOPA decreased the radioactivity levels in the PC-3 tumors by ~50%, whereas no decrease was observed in the accumulation of [<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP.</p></div><div id="FEHTP18F.Other_NonPrimate_Mammals"><h3>Other Non-Primate Mammals</h3><p>[<a href="/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=FEHTP%20and%20%28pig%20or%20dog%20or%20rabbit%20or%20sheep%29" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed</a>]</p><p>No publication is currently available.</p></div><div id="FEHTP18F.NonHuman_Primates"><h3>Non-Human Primates</h3><p>[<a href="/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=FEHTP%20AND%20%28primate%20not%20human%29" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed</a>]</p><p>No publication is currently available.</p></div></div><div id="FEHTP18F.Human_Studies"><h2 id="_FEHTP18F_Human_Studies_">Human Studies</h2><p>[<a href="/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=FEHTP%20and%20human" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubMed</a>]</p><p>No publication is currently available.</p></div><div id="FEHTP18F.References"><h2 id="_FEHTP18F_References_">References</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.1">Jager P.L., Vaalburg W., Pruim J., de Vries E.G., Langen K.J., Piers D.A.
|
|
<em>Radiolabeled amino acids: basic aspects and clinical applications in oncology.</em>
|
|
<span><span class="ref-journal">J Nucl Med. </span>2001;<span class="ref-vol">42</span>(3):432–45.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11337520" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11337520</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>2.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.2">Laverman P., Boerman O.C., Corstens F.H., Oyen W.J.
|
|
<em>Fluorinated amino acids for tumour imaging with positron emission tomography.</em>
|
|
<span><span class="ref-journal">Eur J Nucl Med Mol Imaging. </span>2002;<span class="ref-vol">29</span>(5):681–90.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11976809" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11976809</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>3.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.3">Herholz K., Heiss W.D.
|
|
<em>Positron emission tomography in clinical neurology.</em>
|
|
<span><span class="ref-journal">Mol Imaging Biol. </span>2004;<span class="ref-vol">6</span>(4):239–69.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15262239" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15262239</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>4.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.4">Langen K.J., Pauleit D., Coenen H.H.
|
|
<em>3-[(123)I]Iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications.</em>
|
|
<span><span class="ref-journal">Nucl Med Biol. </span>2002;<span class="ref-vol">29</span>(6):625–31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12234586" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12234586</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>5.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.5">Lahoutte T., Caveliers V., Camargo S.M., Franca R., Ramadan T., Veljkovic E., Mertens J., Bossuyt A., Verrey F.
|
|
<em>SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation.</em>
|
|
<span><span class="ref-journal">J Nucl Med. </span>2004;<span class="ref-vol">45</span>(9):1591–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15347729" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15347729</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>6.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.6">Langen K.J., Jarosch M., Muhlensiepen H., Hamacher K., Broer S., Jansen P., Zilles K., Coenen H.H.
|
|
<em>Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas.</em>
|
|
<span><span class="ref-journal">Nucl Med Biol. </span>2003;<span class="ref-vol">30</span>(5):501–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12831987" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12831987</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>7.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.7">Saier M.H., Daniels G.A., Boerner P., Lin J.
|
|
<em>Neutral amino acid transport systems in animal cells: potential targets of oncogene action and regulators of cellular growth.</em>
|
|
<span><span class="ref-journal">J Membr Biol. </span>1988;<span class="ref-vol">104</span>(1):1–20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3054116" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3054116</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>8.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.8">Kramer S.D., Mu L., Muller A., Keller C., Kuznetsova O.F., Schweinsberg C., Franck D., Muller C., Ross T.L., Schibli R., Ametamey S.M.
|
|
<em>5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.</em>
|
|
<span><span class="ref-journal">J Nucl Med. </span>2012;<span class="ref-vol">53</span>(3):434–42.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22331220" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22331220</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>9.</dt><dd><div class="bk_ref" id="FEHTP18F.REF.9">Li R., Wu S.C., Wang S.C., Fu Z., Dang Y., Huo L.
|
|
<em>Synthesis and evaluation of l-5-(2-[(18)F]fluoroethoxy)tryptophan as a new PET tracer.</em>
|
|
<span><span class="ref-journal">Appl Radiat Isot. </span>2010;<span class="ref-vol">68</span>(2):303–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19906535" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19906535</span></a>]</div></dd></dl></dl></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK98128_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><div class="contrib half_rhythm"><span itemprop="author">Kam Leung</span>, PhD<div class="affiliation small">National Center for Biotechnology Information, NLM, NIH, Bethesda, MD<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.mln.ibcn@dacim" class="oemail">vog.hin.mln.ibcn@dacim</a></div></div><div class="small">Corresponding author.</div></div><h3>Publication History</h3><p class="small">Created: <span itemprop="datePublished">March 3, 2012</span>; Last Update: <span itemprop="dateModified">June 28, 2012</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p><a href="http://www.ncbi.nlm.nih.gov/" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">National Center for Biotechnology Information (US)</a>, Bethesda (MD)</p><h3>NLM Citation</h3><p>Leung K. 5-(2-[18F]Fluoroethoxy)-L-tryphan. 2012 Mar 3 [Updated 2012 Jun 28]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. <span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/micad/BrFPN/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/micad/FPHBF-2-18F/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobFEHTP18FTncchemicalname5218ffluoroet"><div id="FEHTP18F.T.nc_chemical_name5218ffluoroet" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK98128/table/FEHTP18F.T.nc_chemical_name5218ffluoroet/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__FEHTP18F.T.nc_chemical_name5218ffluoroet_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Chemical name:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><span class="small-caps">5-(2-</span>[<sup>18</sup>F]Fluoroethoxy)-<span class="small-caps">L</span>-tryphan</td><td rowspan="9" colspan="1" style="text-align:center;vertical-align:middle;">
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/substance/136345882" title="View this structure in PubChem" class="img_link" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem"><img src="https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=l&sid=136345882" alt="image 136345882 in the ncbi pubchem database" /></a>
|
|
</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Abbreviated name:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">[<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP, 5-<sup>18</sup>FEHTP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Synonym:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><span class="small-caps">L</span>-<span class="small-caps">5-(2-</span>[<sup>18</sup>F]Fluoroethoxy)tryphan</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Agent category:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Compound</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Target:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">L-type amino acid transporter 1 (LAT1)</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Target category:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Amino acid uptake</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Method of detection:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Positron emission tomography (PET)</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Source of signal:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><sup>18</sup>F</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Activation:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No</td></tr><tr><td rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">
|
|
<b>Studies:</b>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<ul class="simple-list"><li class="half_rhythm"><div>
|
|
<img alt="Checkbox" src="/corehtml/pmc/css/bookshelf/2.26/img/studies.checkbox.png" />
|
|
<i>In vitro</i>
|
|
|
|
</div></li><li class="half_rhythm"><div>
|
|
<img alt="Checkbox" src="/corehtml/pmc/css/bookshelf/2.26/img/studies.checkbox.png" /> Rodents
|
|
</div></li></ul>
|
|
</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Click on the above structure for additional information in <a href="http://pubchem.ncbi.nlm.nih.gov/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PubChem</a>.</td></tr></tbody></table></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal105 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|